ConductScience.org, home

Paper21994367

Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.

Ebrahimi-Fakhari D and 7 others. J Neurosci, 2011. Cited by 320 papers, by iCite.

Cite this record

ConductScience Library. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. Papers, record 21994367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21994367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.
PubMed
Journal
J Neurosci
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
320
iCite
Relative citation ratio, by iCite
8.59
iCite
Revised in PubMed
2022-04-08
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ebrahimi-Fakhari DDarius
2Cantuti-Castelvetri IIppolita
3Fan ZZhanyun
4Rockenstein EEdward
5Masliah EEliezer
6Hyman BTBradley T
7McLean PJPamela J
8Unni VKVivek K

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutophagyMajor topic
LysosomesMajor topic
Proteasome Endopeptidase ComplexMajor topic
Signal TransductionMajor topic
UbiquitinMajor topic
alpha-SynucleinMajor topic
Age Factors
Analysis of Variance
Animals
Dose-Response Relationship, Drug
Drug Combinations
Enzyme Inhibitors
Gene Expression Regulation
Green Fluorescent Proteins
Humans
Mice
Mice, Transgenic
RNA, Messenger
Receptor, Platelet-Derived Growth Factor beta

Source PubMed

Download CSV of topics

Grants14

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AG10435NIA NIH HHSUnited StatesP01AG010435PubMed and NIHNIH RePORTER
AG18840NIA NIH HHSUnited StatesPubMedPubMed
T32 NS048005NINDS NIH HHSUnited StatesT32NS048005PubMed and NIHNIH RePORTER
R01 NS063963NINDS NIH HHSUnited StatesR01NS063963PubMed and NIHNIH RePORTER
P30NS045776NINDS NIH HHSUnited StatesP30NS045776PubMed and NIHNIH RePORTER
NS063963NINDS NIH HHSUnited StatesR01NS063963PubMed and NIHNIH RePORTER
P01 AG010435NIA NIH HHSUnited StatesP01AG010435PubMed and NIHNIH RePORTER
P01 AG022074NIA NIH HHSUnited StatesP01AG022074PubMed and NIHNIH RePORTER
P30 NS045776NINDS NIH HHSUnited StatesP30NS045776PubMed and NIHNIH RePORTER
T32 AG000222NIA NIH HHSUnited StatesT32AG000222PubMed and NIHNIH RePORTER
NS038372NINDS NIH HHSUnited StatesP50NS038372PubMed and NIHNIH RePORTER
K08 NS069625NINDS NIH HHSUnited StatesK08NS069625PubMed and NIHNIH RePORTER
P50 NS038372NINDS NIH HHSUnited StatesP50NS038372PubMed and NIHNIH RePORTER
AG022074NIA NIH HHSUnited StatesP01AG022074PubMed and NIHNIH RePORTER

Download CSV of grants

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121187150Studying protein degradation pathways in vivo using a cranial window-based approach.Methods2011https://conductscience.org/library/papers/21187150PubMed
210567343Degradation of alpha-synuclein by proteasome.J Biol Chem1999https://conductscience.org/library/papers/10567343PubMed
311734199alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.FEBS Lett2001https://conductscience.org/library/papers/11734199PubMed
412971891Parkinson's disease: mechanisms and models.Neuron2003https://conductscience.org/library/papers/12971891PubMed
517712358Autophagy: from phenomenology to molecular understanding in less than a decade.Nat Rev Mol Cell Biol2007https://conductscience.org/library/papers/17712358PubMed
615333840Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.Science2004https://conductscience.org/library/papers/15333840PubMed
717362839Autophagy and neurodegeneration: when the cleaning crew goes on strike.Lancet Neurol2007https://conductscience.org/library/papers/17362839PubMed
816192271HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.J Biol Chem2005https://conductscience.org/library/papers/16192271PubMed
916713278Proteasome dysfunction in aged human alpha-synuclein transgenic mice.Neurobiol Dis2006https://conductscience.org/library/papers/16713278PubMed
1021303699Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.Neurobiol Dis2011https://conductscience.org/library/papers/21303699PubMed
1120174468Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.PLoS One2010https://conductscience.org/library/papers/20174468PubMed
1214593171alpha-Synuclein locus triplication causes Parkinson's disease.Science2003https://conductscience.org/library/papers/14593171PubMed
131832676Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells.J Biol Chem1991https://conductscience.org/library/papers/1832676PubMed
1419525899Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.J Neuropathol Exp Neurol2009https://conductscience.org/library/papers/19525899PubMed
1515451225Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.Lancet2004https://conductscience.org/library/papers/15451225PubMed
1621163350Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging.Methods2011https://conductscience.org/library/papers/21163350PubMed
1719250912Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates.Mol Cell2009https://conductscience.org/library/papers/19250912PubMed
1812481023Endoproteolytic activity of the proteasome.Science2003https://conductscience.org/library/papers/12481023PubMed
1917287515Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.J Neurosci2007https://conductscience.org/library/papers/17287515PubMed
2018083104Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.Cell2007https://conductscience.org/library/papers/18083104PubMed

See all 83 referencesDownload CSV of references

Cited by227

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 320 citations.

PMIDTitleJournalYearIn PapersSource
42577502Research progress on the α-synuclein-lysosome axis in Parkinson's disease: molecular mechanisms of protein aggregation, autophagy dysfunction, and therapeutic targeting.Front Neurosci2026https://conductscience.org/library/papers/42577502PubMed
42552063Recent Advances in Autophagy and Immunotherapy for the Clearance of Aggregated α-Synuclein in Parkinson's Disease.Aging Dis2025https://conductscience.org/library/papers/42552063PubMed
42445617Astrocytes in Parkinson's Disease: From Guardians to Accomplices.Clin Interv Aging2026https://conductscience.org/library/papers/42445617PubMed
42076898Copper Overload Affects α-Synuclein Clearance Mechanisms in a Parkinson's Disease In Vitro Model.Adv Biol (Weinh)2026https://conductscience.org/library/papers/42076898PubMed
41968682Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson's Disease: A Comprehensive Review.Curr Neuropharmacol2026https://conductscience.org/library/papers/41968682PubMed
41959207Rise-and-fall dynamics reveal a molecular and cellular vulnerability axis in prion-like α-synuclein propagation.bioRxiv2026https://conductscience.org/library/papers/41959207PubMed
41838907The α-synuclein proteostasis network and its translational applications in Parkinson's disease.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41838907PubMed
41820807Toxic mechanisms of amyloid oligomers and therapeutic strategies.Protein Sci2026https://conductscience.org/library/papers/41820807PubMed
41750151FGF-FGFR Signaling in Parkinson's Disease: Mechanistic Links to Ferroptosis and Neuroprotection.Brain Sci2026https://conductscience.org/library/papers/41750151PubMed
41146299Modulation of O-GlcNAc cycling influences α-synuclein amplification, degradation, and associated neuroinflammatory pathology.Mol Neurodegener2025https://conductscience.org/library/papers/41146299PubMed
40940751PLEKHM1 Overexpression Impairs Autophagy and Exacerbates Neurodegeneration in rAAV-α-Synuclein Mice.Cells2025https://conductscience.org/library/papers/40940751PubMed
40892950KFERQ-selective protein autophagy in Caenorhabditis elegans depends on LMP-1.PLoS One2025https://conductscience.org/library/papers/40892950PubMed
40589152Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology.J Parkinsons Dis2026https://conductscience.org/library/papers/40589152PubMed
40509661Clearance Pathways for α-Synuclein in Parkinson's Disease.J Neurochem2025https://conductscience.org/library/papers/40509661PubMed
40508212α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges.Int J Mol Sci2025https://conductscience.org/library/papers/40508212PubMed
40375958NFE2L1 as a central regulator of proteostasis in neurodegenerative diseases: interplay with autophagy, ferroptosis, and the proteasome.Front Mol Neurosci2025https://conductscience.org/library/papers/40375958PubMed
40368903Intermittent fasting reduces alpha-synuclein pathology and functional decline in a mouse model of Parkinson's disease.Nat Commun2025https://conductscience.org/library/papers/40368903PubMed
40193596Peptidomimetics Activating the Proteasome: A New Perspective for Parkinson's Treatment.J Med Chem2025https://conductscience.org/library/papers/40193596PubMed
39936034Mechanisms and roles of membrane-anchored ATG8s.Front Cell Dev Biol2025https://conductscience.org/library/papers/39936034PubMed
39759118TFE3-mediated neuroprotection: Clearance of aggregated α-synuclein and accumulated mitochondria in the AAV-α-synuclein model of Parkinson's disease.Genes Dis2025https://conductscience.org/library/papers/39759118PubMed

See all 227 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADGRL122859PubTator's text mininghttps://conductscience.org/library/genes/22859NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
MAP1LC3A84557PubTator's text mininghttps://conductscience.org/library/genes/84557NCBI Gene
PDGFB5155PubTator's text mininghttps://conductscience.org/library/genes/5155NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene
SQSTM18878PubTator's text mininghttps://conductscience.org/library/genes/8878NCBI Gene
TUBA1B10376PubTator's text mininghttps://conductscience.org/library/genes/10376NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21994367

GET https://conductscience.org/api/papers/v1/21994367/references?page=2